Gut microbiome in DLBCL patients undergoing first‐line R‐CHOP regimen—The Oncopassport Study.

Gut microbiome in DLBCL patients undergoing first-line R-CHOP regimen - The Oncopassport Study Reconstructing GM dynamics in DLBCL patients from diagnosis to the end of R-CHOP may provide important information for patient management. B Introduction: b The search of biomarkers that can predict and influence treatment outcomes of diffuse large B-cell lymphoma (DLBCL) is constantly evolving, especially in the front-line setting. [Extracted from the article]